We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Univest Financial
UVSP
$1.23B
| $14K | ﹤0.01% |
409
+75
| +22% | +$2.54K |
|
2052
United States Lime & Minerals
USLM
$3.05B
| $14K | ﹤0.01% |
107
-4
| -4% | -$481 |
|
2053
Seacoast Banking Corp of Florida
SBCF
$3.21B
| $14K | ﹤0.01% |
461
-60
| -12% | -$1.94K |
|
|
NXRT
2054
NexPoint Residential Trust
NXRT
$661M
| $13.9K | ﹤0.01% |
558
+41
| +8% | +$1.18K |
|
2055
First Mid Bancshares
FMBH
$1.33B
| $13.9K | ﹤0.01% |
338
+103
| +44% | +$4.27K |
|
2056
Tompkins Financial
TMP
$1.33B
| $13.9K | ﹤0.01% |
176
+45
| +34% | +$3.5K |
|
2057
TriMas Corp
TRS
$1.44B
| $13.9K | ﹤0.01% |
386
+23
| +6% | +$825 |
|
2058
Seneca Foods Class A
SENEA
$1.11B
| $13.8K | ﹤0.01% |
+91
| New | +$11.8K |
|
|
PRA
2059
DELISTED
ProAssurance
PRA
| $13.7K | ﹤0.01% |
556
+4
| +0.7% | +$98 |
|
2060
Atlas Energy Solutions
AESI
$1.63B
| $13.7K | ﹤0.01% |
1,045
-8
| -0.8% | -$93 |
|
2061
Cracker Barrel
CBRL
$1.16B
| $13.5K | ﹤0.01% |
481
+130
| +37% | +$3.96K |
|
2062
First Merchants
FRME
$2.64B
| $13.5K | ﹤0.01% |
348
+28
| +9% | +$1.09K |
|
2063
Vir Biotechnology
VIR
$1.58B
| $13.4K | ﹤0.01% |
+1,499
| New | +$11.9K |
|
2064
BlackSky Technology
BKSY
$845M
| $13.3K | ﹤0.01% |
528
+31
| +6% | +$741 |
|
|
GRDN
2065
Guardian Pharmacy Services
GRDN
$2.5B
| $13.2K | ﹤0.01% |
351
+74
| +27% | +$2.42K |
|
2066
Annexon
ANNX
$868M
| $13.1K | ﹤0.01% |
+2,367
| New | +$13.3K |
|
2067
Cullinan Oncology
CGEM
$1.06B
| $13.1K | ﹤0.01% |
+922
| New | +$11.8K |
|
2068
SkyWater Technology
SKYT
$1.51B
| $13K | ﹤0.01% |
476
+108
| +29% | +$3.17K |
|
|
AMWD
2069
DELISTED
American Woodmark
AMWD
| $12.9K | ﹤0.01% |
324
+75
| +30% | +$3.98K |
|
2070
Hilltop Holdings
HTH
$2.22B
| $12.9K | ﹤0.01% |
360
-3
| -0.8% | -$110 |
|
2071
Kirby Corp
KEX
$7.97B
| $12.9K | ﹤0.01% |
97
+2
| +2% | +$253 |
|
2072
Lennar Class B
LEN.B
$19.4B
| $12.9K | ﹤0.01% |
153
| – | – |
|
2073
ACV Auctions
ACVA
$1.32B
| $12.9K | ﹤0.01% |
3,034
+965
| +47% | +$6.32K |
|
2074
Geron
GERN
$930M
| $12.8K | ﹤0.01% |
8,599
-570
| -6% | -$866 |
|
2075
Fulgent Genetics
FLGT
$567M
| $12.8K | ﹤0.01% |
803
+303
| +61% | +$6.58K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.